What is Puregon 900 IU/1.08 ml inj. sol. s.c. cartr. used for?

( ARTG ) Female: Anovulatory infertility and; controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs (e.g. in vitro fertilisation and related procedures). Male: For the treatment of deficient spermatogenesis due to hypogonadotrophic hypogonadism.

What pharmaceutical form is Puregon 900 IU/1.08 ml inj. sol. s.c. cartr. available in?

Puregon 900 IU/1.08 ml inj. sol. s.c. cartr.: Solution for injection (Subcutaneous use)

What are the side effects of Puregon 900 IU/1.08 ml inj. sol. s.c. cartr.?

You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Can Puregon 900 IU/1.08 ml inj. sol. s.c. cartr. be used during pregnancy?

( AHT ) For the active ingredient follitropin beta You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What ATC class does Puregon 900 IU/1.08 ml inj. sol. s.c. cartr. belong to?

Puregon 900 IU/1.08 ml inj. sol. s.c. cartr.: ATC G03GA06 Follitropin Beta. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

OTC

Puregon 900 IU/1.08 ml inj. sol. s.c. cartr.

Solution for injection

INN: Human Follitropin Beta, Recombinant

Data updated: 2026-04-11

Available in:

🇩🇪🇬🇧🇹🇷

Form

Solution for injection

Dosage

—

Route

Subcutaneous use

Storage

—

About This Product

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.